UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
SAN DIEGO, Texas
Total Received
$1.67B
Total Awards
374
State
Texas
Last Updated
Mar 20, 2026
Yearly Funding Trend
$1.51B24
$132.0M25
$21.4M26
Top 50 Awards to UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_U24OD023176_075 TECHNOLOGY TO EMPOWER CHANGES IN HEALTH (TECH) NETWORK PARTICIPANT TECHNOLOGIES CENTER - ABSTRACT/PROJECT SUMMARY REMARKABLE ADVANCEMENTS IN OUR NATION'S DIGITAL INFRASTRUCTURE CO… | Department of Health and Human Services National Institutes of Health | 93.368 21ST CENTURY CURES ACT - PRECISION MEDICINE INITIATIVE | LA JOLLA, CA-50 | 2024 | $202,512,667 |
ASST_NON_UM1AI144462_075 CONSORTIUM FOR HIV/AIDS VACCINE DEVELOPMENT - PROJECT SUMMARY/ABSTRACT (30 LINES) THE OVERARCHING GOAL OF THIS CHAVD IS TO DEVELOP A SEQUENTIAL HIV VACCINE REGIMEN THAT INDUCES SU… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $201,437,825 |
ASST_NON_U19AI171443_075 CENTER FOR ANTIVIRAL MEDICINES & PANDEMIC PREPAREDNESS (CAMPP) - SUMMARY THE ONGOING COVID-19 PANDEMIC HAS BROUGHT TO LIGHT AN URGENT NEED TO ENHANCE THE THERAPEUTIC PREPAREDNESS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2024 | $67,624,156 |
ASST_NON_OT2OD035580_075 THE PARTICIPANT CENTER: EMPOWERING ALL OF US RESEARCH PROGRAM PARTICIPATION ACROSS THE UNITED STATES - THE PARTICIPANT CENTER (TPC) WILL 1) MAINTAIN CAPABILITIES THAT ENABLE FULL… | Department of Health and Human Services National Institutes of Health | 93.368 21ST CENTURY CURES ACT - PRECISION MEDICINE INITIATIVE | CA-90 | 2024 | $64,505,370 |
ASST_NON_U19AI100627_075 SYSTEMS APPROACH TO IMMUNITY AND INFLAMMATION - SUMMARY THE INNATE IMMUNE RESPONSE IS A DOUBLE-EDGED SWORD; IT IS ABSOLUTELY REQUIRED FOR HOST DEFENSE, BUT UNREGULATED, CAUSES INF… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $49,114,253 |
ASST_NON_P60AA006420_075 CNS EFFECTS OF ALCOHOL: CELLULAR NEUROBIOLOGY - CHANGES TO PROPOSED REVISED ACTIVITIES ARE IN RED REVISED ABSTRACT OVERALL THE SCRIPPS RESEARCH INSTITUTE-ALCOHOL RESEARCH CENTER… | Department of Health and Human Services National Institutes of Health | 93.273 ALCOHOL RESEARCH PROGRAMS | CA-90 | 2024 | $32,819,209 |
ASST_NON_UL1TR002550_075 SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE - OVERALL ABSTRACT THE SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE (STSI) IS THE CENTER OF THE SCRIPPS HUB, FORMED IN 2007, DEDICATED TO ACCELE… | Department of Health and Human Services National Institutes of Health | 93.368 21ST CENTURY CURES ACT - PRECISION MEDICINE INITIATIVE | LA JOLLA, CA-50 | 2024 | $28,405,106 |
ASST_NON_U19AI135995_075 CENTER FOR VIRAL SYSTEMS BIOLOGY (CVISB) - PROJECT SUMMARY - CENTER FOR VIRAL SYSTEMS BIOLOGY (CVISB) THE COVID-19 PANDEMIC IS A STARK REMINDER OF THE THREAT POSED BY INFECTIOUS D… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2024 | $26,011,095 |
ASST_NON_UM1AI164561_075 REVERSING IMMUNE DYSFUNCTION FOR HIV-1 ERADICATION - PROJECT SUMMARY ALTHOUGH THE RATE OF NEW HIV INFECTIONS HAS DECREASED, CONTAINMENT AND EVENTUAL ERADICATION OF THE HIV PANDEMI… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $25,003,080 |
ASST_NON_UM1TR004407_075 SCRIPPS CLINICAL AND TRANSLATIONAL SCIENCE HUB - THE SCRIPPS RESEARCH TRANSLATIONAL INSTITUTE (SRTI) IS THE FOUNDATION FOR THE SCRIPPS HUB AND IS DEDICATED TO ACCELERATING SCIENCE… | Department of Health and Human Services National Institutes of Health | 93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES | LA JOLLA, CA-50 | 2024 | $18,113,488 |
ASST_NON_P01AI157299_075 ELICITING NEUTRALIZING ANTIBODIES AND B CELL RESPONSES USING NOVEL HIV ENV IMMUNOGENS IN NON-HUMAN PRIMATES - NEUTRALIZING ANTIBODIES ARE LIKELY TO BE REQUIRED FOR AN EFFECTIVE HI… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $17,277,936 |
ASST_NON_U01AI151812_075 WEST AFRICAN EMERGING INFECTIOUS DISEASE RESEARCH CENTER (WA-EIDRC) - ABSTRACT ENSURING A WORLD SAFE FROM MICROBIAL THREATS IS A PRESSING CHALLENGE, AS OUTBREAKS EXACT TOLLS ON HU… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2024 | $13,205,873 |
ASST_NON_P01HL152958_075 NEUTROPHIL LINEAGE IN INFLAMMATION - ABSTRACT NEUTROPHILS CONSTITUTE THE FIRST LINE OF CELLULAR DEFENSE AGAINST PATHOGENIC MICROORGANISMS. IN RESPONSE TO PRO- INFLAMMATORY CUES, U… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $12,398,549 |
ASST_NON_R01GM031001_075 CYTOCHROME P-450 POLYMORPHISM - CYTOCHROME P450 MONOOXYGENASES OFTEN DETERMINE THE CLEARANCE OF CANDIDATE DRUGS LIMITING THEIR THERAPEUTIC EFFICACY. THESE ENZYMES CAN ALSO BE SOUR… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | LA JOLLA, CA-50 | 2024 | $11,549,628 |
ASST_NON_R35GM118176_075 SCALABLE SYNTHESIS AND NEW BOND DISCONNECTIONS - PROJECT SUMMARY/ABSTRACT NATURAL PRODUCTS HAVE LONG HELD SOCIETAL VALUE AS FOLK MEDICINES, AND EVEN IN THIS MODERN ERA, MANY FDA-A… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | CA-90 | 2024 | $11,514,019 |
ASST_NON_U01AA013498_075 9/10 ELECTROPHYSIOLOGY OF ALCOHOL IN EXTENDED AMYGDALA - THIS IS A COMPETITIVE U01 RENEWAL APPLICATION UNDER THE INTEGRATIVE NEUROSCIENCE INITIATIVE ON ALCOHOLISM- NEUROIMMUNE (IN… | Department of Health and Human Services National Institutes of Health | 93.273 ALCOHOL RESEARCH PROGRAMS | LA JOLLA, CA-50 | 2024 | $10,639,405 |
ASST_NON_P01AI168251_075 BROADLY EFFECTIVE HCV VACCINE - PROGRAM SUMMARY THE OVERARCHING GOAL OF THIS P01 PROPOSAL IS TO DEVELOP NOVEL HEPATITIS C VIRUS (HCV) VACCINE CANDIDATES THAT CAN ELICIT POTENT BRO… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $10,492,051 |
ASST_NON_W81XWH2010270_097 DEVELOPMENT AND ADVANCEMENT OF BROAD-SPECTRUM RESPIRATORY ANTIVIRALS DE-OBLIGATE FUNDS TO CLOSE AWARD | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | LA JOLLA, CA-50 | 2024 | $10,202,542 |
ASST_NON_T32AA007456_075 NEUROPSYCHOPHARMACOLOGY: MULTIDISCIPLINARY TRAINING - THE PURPOSE OF THIS INSTITUTIONAL T32 PROGRAM IS TO PROVIDE PROMISING YOUNG SCIENTISTS WITH MENTOR-BASED TRAINING IN A DYNAMI… | Department of Health and Human Services National Institutes of Health | 93.273 ALCOHOL RESEARCH PROGRAMS | CA-90 | 2024 | $9,660,806 |
ASST_NON_R01GM084019_075 LIGAND-PROMOTED ENANTIOSELECTIVE C-H ACTIVATION REACTION - PROJECT SUMMARY DESYMMETRIZING ACTIVATION OF PROCHIRAL C–H BONDS VIA METAL INSERTION HAS EMERGED AS A POTENTIALLY TRANS… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | CA-90 | 2024 | $9,464,875 |
ASST_NON_R01GM069832_075 AUTODOCK SUITE: HIGH PERFORMANCE SOFTWARE ENVIRONMENT FOR DRUG DESIGN - PROJECT SUMMARY COMPUTATIONAL DOCKING IS AN ESSENTIAL TOOL FOR DRUG DISCOVERY AND DESIGN, AND IT HAS BEEN… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | LA JOLLA, CA-50 | 2024 | $9,105,711 |
ASST_NON_R35CA231991_075 CHEMICAL PROTEOMIC PLATFORMS FOR RADICALLY EXPANDING CANCER DRUGGABILITY - CANCER RESEARCH AND TREATMENT HAVE GREATLY BENEFITED FROM ADVANCES IN DNA SEQUENCING METHODS, WHICH HAVE… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | CA-90 | 2024 | $8,619,965 |
ASST_NON_R01HL118114_075 MANAGING ATHEROSCLEROSIS BY MODULATING HDL FUNCTION - PROJECT SUMMARY/ABSTRACT ATHEROSCLEROSIS IS THE LEADING CAUSE OF HUMAN MORTALITY WORLDWIDE. THERE HAS BEEN A GREAT INTEREST… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $8,504,165 |
ASST_NON_R01HL088256_075 VESICULAR TRAFFICKING MECHANISMS REGULATING GRANULOCYTE FUNCTION - PROJECT SUMMARY: INTRACELLULAR VESICULAR TRANSPORT IS ESSENTIAL FOR ALL ASPECTS OF NEUTROPHIL PHYSIOLOGY AND DEF… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CA-90 | 2024 | $8,282,326 |
ASST_NON_RC2DK114785_075 CHEMOPROTEOMIC IDENTIFICATION AND THERAPEUTIC VALIDATION OF PROTEINS OF METABOLIC SIGNIFICANCE - ABSTRACT THERE IS A NEED TO DEVELOP DIABETES DRUGS WITH A MECHANISM OF ACTION DIST… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | LA JOLLA, CA-50 | 2024 | $8,249,685 |
ASST_NON_R01HL081046_075 REGULATION OF CELLULAR FUNCTIONS BY THE PLASMINOGEN RECEPTOR, PLG-RKT - PROJECT SUMMARY/ABSTRACT THE PLASMINOGEN ACTIVATION SYSTEM EXTENSIVELY REGULATES THE INFLAMMATORY RESPONSE… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CA-90 | 2024 | $8,193,664 |
ASST_NON_R01DK046335_075 PROBING THE BIOCHEMICAL MECHANISM OF AMYLOID DISEASE - WE SEEK TO UNDERSTAND HOW THE PROCESS OF TRANSTHYRETIN (TTR) AGGREGATION, AND WHICH AGGREGATE STRUCTURES LEAD TO THE DYSFUNC… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | LA JOLLA, CA-50 | 2024 | $8,058,387 |
ASST_NON_R01AI136621_075 DISSECTING POLYCLONAL SERA TO REVEAL CORRELATES OF PRODUCTIVE IMMUNE RESPONSES TO HIV - PROJECT SUMMARY/ABSTRACT RATIONAL, STRUCTURE-BASED IMMUNOGEN DESIGN FOR HIV VACCINE DEVELOP… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $8,016,616 |
ASST_NON_R01AI147826_075 DESIGN AND TESTING OF GERMLINE-TARGETING AND BOOSTING IMMUNOGENS TO ELICIT 10E8-LIKE BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV - INDUCTION OF BROADLY NEUTRALIZING ANTIBODIES (BN… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2025 | $7,959,922 |
ASST_NON_R01AI073148_075 KNOCK-IN MICE EXPRESSING GERMLINE-REVERTED BROADLY NEUTRALIZING HIV ANTIBODIES - THIS IS A RENEWAL R01 APPLICATION TO EXPLOIT KNOCK-IN MOUSE MODELS AND HYPERMUTATING HUMAN B CELL… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2025 | $7,688,019 |
ASST_NON_R35CA197582_075 CANCER GENES: TRANSLATING BASICS TO APPLICATIONS - DESCRIPTION (PROVIDED BY APPLICANT): THE PROPOSAL FOCUSES ON MOLECULAR MECHANISMS OF ONCOGENESIS. IT INCLUDES THREE MAJOR P… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LA JOLLA, CA-50 | 2024 | $7,520,540 |
ASST_NON_R01MH100175_075 PROTEOGENETICS OF AUTISM SPECTRUM DISORDERS - PROJECT SUMMARY/ ABSTRACT THE GOAL OF THE PROPOSED RESEARCH IS TO USE PROTEOMICS ON SAMPLES FROM PATIENT-DERIVED CELLS WITH DEFINED D… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | LA JOLLA, CA-50 | 2024 | $7,358,607 |
ASST_NON_R01HL142975_075 REGULATION OF PROTEIN C PATHWAYS - PROJECT SUMMARY/ABSTRACT ACTIVATED PROTEIN C (APC) IS A NATURALLY OCCURRING PLASMA SERINE PROTEASE THAT HAS BEEN TRANSLATED TO THE CLINIC AS A R… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $7,273,484 |
ASST_NON_R01CA042056_075 ANTITUMOR ANTIBIOTICS - ABSTRACT. STUDIES ON THE TOTAL SYNTHESIS OF ANTITUMOR ANTIBIOTICS ARE DETAILED, INCLUDING VINBLASTINE, VINCRISTINE, RELATED VINCA ALKALOIDS AND THEIR ANALO… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | LA JOLLA, CA-50 | 2024 | $7,254,028 |
ASST_NON_R01HL095524_075 MODULATION OF LUNG DISEASE BY GENETIC/EPIGENETIC PROFILING - PROJECT SUMMARY/ABSTRACT: THERAPEUTIC MANAGEMENT OF LUNG DISORDERS TRIGGERED BY THE LOSS-OF-FUNCTION OF THE CYSTIC FIB… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $7,069,838 |
ASST_NON_R01AI132317_075 GERMLINE TARGETING INFLUENZA IMMUNOGENS - ABSTRACT INFLUENZA VIRUS IS A MAJOR PUBLIC HEALTH BURDEN THAT IS CURRENTLY CONTROLLED BY YEARLY VACCINATION. PROTECTION IS LARGELY CONFER… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2025 | $6,994,015 |
ASST_NON_DP1DA041722_075 DEVELOPMENT OF A TARGETED NITRIC OXIDE-RELATED DRUG TO TREAT SARS-COV-2 - COVID-19-RELATED ADMINISTRATIVE SUPPLEMENT TO DP1 DA041722 UNDER PA-18-591 AND NOT-DA-20-047 PROJECT SUMM… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS | LA JOLLA, CA-50 | 2024 | $6,821,631 |
ASST_NON_R01AG075862_075 CELL SPECIFIC PERTURBATIONS OF THE PROTEOME IN ALZHEIMER'S DISEASE - ALZHEIMER’S DISEASE (AD) IS THE LEADING CAUSE OF AGING-RELATED COGNITIVE DECLINE, AFFECTING MORE THAN 5 MILLIO… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | LA JOLLA, CA-50 | 2024 | $6,610,744 |
ASST_NON_R01CA041101_075 BIOLOGICALLY ACTIVE CYCLIC PEPTIDES - ABSTRACT. THE GLYCOPEPTIDE ANTIBIOTICS ARE THE MOST IMPORTANT CLASS OF DRUGS USED IN THE TREATMENT OF RESISTANT BACTERIAL INFECTIONS, INCLUDI… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | CA-90 | 2024 | $6,542,769 |
ASST_NON_R35GM122606_075 UNUSUAL PHARMACOPHORES AND NEW TOOLS FOR CROSS-COUPLING - ABSTRACT BIOASSAY-GUIDED FRACTIONATION OF CELLS UNCOVERS SMALL MOLECULES THAT BIND RECEPTORS IN NEW AND UNEXPECTED WAYS.… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | CA-90 | 2024 | $6,362,107 |
ASST_NON_R35NS105067_075 MECHANISMS OF FORCE SENSING IN THE NERVOUS SYSTEM - UNLIKE SIGHT, TASTE AND SMELL, MECHANICAL SENSES EXTEND BEYOND A SINGLE SENSORY ORGAN, AND ENCOMPASS PROCESSES AS DIVERSE AS HE… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | CA-90 | 2024 | $6,072,945 |
ASST_NON_R01HL104165_075 STRUCTURE-FUNCTION OF CYTOPROTECTIVE COAGULATION PROTEASES AND THEIR RECEPTORS - PROJECT SUMMARY THIS APPLICATION SEEKS TO IMPROVE BASIC UNDERSTANDING OF THE MOLECULAR MECHANISMS… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CA-90 | 2024 | $6,072,866 |
ASST_NON_P01AI172525_075 MULTIDIMENSIONAL DEVELOPMENT OF HIGH-AFFINITY ANTI-GLYCAN ANTIBODIES TO FIGHT DEADLY BACTERIAL INFECTIONS - ABSTRACT THE DEVELOPMENT OF IMMUNOTHERAPIES FOCUSED ON THE SURFACE GLYC… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $5,930,384 |
ASST_NON_R01GM083924_075 BIOGPS, BIOTHINGS AND BIOREEL: ILLUMINATING DARK DATA FOR BIOMEDICAL RESEARCH - THE OVERALL GOAL OF THIS PROJECT IS TO PROMOTE THE ACCESSIBILITY AND DISSEMINATION OF BIOMEDICAL IN… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | LA JOLLA, CA-50 | 2024 | $5,624,564 |
ASST_NON_R01AA006059_075 EFFECTS OF ALCOHOL ON SLEEP/ACTIVITY RHYTHMS: FOCUS ON HYPOCRETIN/OREXIN - PROJECT SUMMARY/ABSTRACT CLINICAL STUDIES HAVE DEMONSTRATED THAT DRINKING TYPICALLY BEGINS IN ADOLESCEN… | Department of Health and Human Services National Institutes of Health | 93.273 ALCOHOL RESEARCH PROGRAMS | LA JOLLA, CA-50 | 2024 | $5,620,527 |
ASST_NON_R01AA014351_075 THE NOCICEPTIN ORL1 SYSTEM: TREATMENT TARGET FOR RELAPSE - TREATMENT WITH NALTREXONE (NTX), A NONSELECTIVE Μ, D, K (MOP, DOP, KOP) CLASSICAL OPIOID RECEPTOR ANTAGONIST, IS CONSIDE… | Department of Health and Human Services National Institutes of Health | 93.273 ALCOHOL RESEARCH PROGRAMS | LA JOLLA, CA-50 | 2024 | $5,576,279 |
ASST_NON_R01AG049617_075 INTEGRATIVE OMICS ANALYSIS OF HUMAN CARTILAGE IN AGING AND OSTEOARTHRITIS - ABSTRACT OSTEOARTHRITIS (OA) IS THE MOST PREVALENT JOINT DISEASE. ALTHOUGH MANY DRUG TARGETS HAVE BEEN… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | LA JOLLA, CA-50 | 2024 | $5,563,514 |
ASST_NON_R01AA021667_075 GENE NETWORK PERTURBATIONS IN ALCOHOL DEPENDENCE - A SYSTEMS BIOLOGYAPPROACH - THIS IS THE FIRST COMPETITIVE RENEWAL OF AN INNOVATIVE PROJECT AT THE INTERFACE OF COMPUTATIONAL ANA… | Department of Health and Human Services National Institutes of Health | 93.273 ALCOHOL RESEARCH PROGRAMS | CA-90 | 2024 | $5,551,225 |
ASST_NON_R01GM075995_075 DYNAMIC MODULATION OF P53 ACTIVITY BY ITS DISORDERED REGULATORY DOMAINS - APPROXIMATELY 30% OF THE PROTEINS IN THE HUMAN PROTEOME ARE INTRINSICALLY DISORDERED (IDPS) OR CONTAIN LO… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | LA JOLLA, CA-50 | 2024 | $5,448,488 |
ASST_NON_R01NS087026_075 TRANSCRIPTIONAL CONTROL OF SYNAPTIC PLASTICITY BY CLASS IIA HDACS - THE GOAL OF THIS PROJECT IS TO ELUCIDATE THE MOLECULAR MECHANISMS OF EXPERIENCE-DEPENDENT PLASTICITY OF NEURAL… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | LA JOLLA, CA-50 | 2024 | $5,423,306 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$602.0M
93.368 — 21ST CENTURY CURES ACT - PRECISION MEDICINE INITIATIVE$295.4M
93.859 — BIOMEDICAL RESEARCH AND RESEARCH TRAINING$152.1M
93.273 — ALCOHOL RESEARCH PROGRAMS$102.9M
93.866 — AGING RESEARCH$86.5M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$86.1M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$62.9M
93.279 — DRUG USE AND ADDICTION RESEARCH PROGRAMS$47.1M
93.853 — EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$37.9M
93.350 — NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES$37.3M
Source: USAspending.gov · All Recipients · Texas